Effective advancement
投放时间: 2025-07-11 08:00:00
We invite you to learn more about our upcoming clinical research trial to evaluate the safety and effectiveness of an investigational medication for cardiovascular disease. Your participation could play a vital role in advancing medical research.
Minimum eligibility requirements:
● ≥ 18 years of age with history of Atherosclerotic Cardiovascular Disease defined as Acute Coronary Syndrome or large artery ischemic stroke in the last 1-12 months
● Type 2 Diabetes
● Previous above ankle amputation
● Diagnosis of non-end stage Chronic Kidney Disease
● Current tobacco use
By participating, you may:
● Gain access to investigational medication at no cost.
● Contribute to the advancement of medicine and potentially more effective therapeutics.
搜索关键词 cardiovascular disease trial, clinical research study, investigational medication, diabetes amputation, chronic kidney disease优势 Access to investigational medication at no cost,Contribution to medical advancement,Potential access to more effective therapeutics
展示估值
100447
热度
8480
最新发现时间
2025-07-11 08:00:00
投放天数
210
素材信息
素材类型
素材尺寸
主页ID8289873642118482042
主页名字Tapia Wellness and Research, LLC
适用范围
适用人群both
劣势Potential risks associated with investigational medication,Specific eligibility requirements
情感Hope
人民币汇率走势
CNY
关注我们

新媒网跨境发布
本站原创内容版权归作者及NMedia共同所有,未经许可,禁止以任何形式转载。